MMWR Morb Mortal Wkly Rep. 1995 Jul 21;44(28):525-9.
Pertussis was a major cause of morbidity and mortality among infants and children in the United States during the prevaccine era (i.e., before the mid-1940s). Since pertussis became a nationally reportable disease in 1922, the highest number of pertussis cases (approximately 260,000) was reported in 1934; the highest number of pertussis-related deaths (approximately 9000) occurred in 1923. Following the licensure of whole-cell pertussis vaccine combined with diphtheria and tetanus toxoids (DTP) in 1949 and the widespread use of DTP among infants and children, the incidence of reported pertussis declined to a historical low of 1010 cases in 1976 (Figure 1). However, since the early 1980s, reported pertussis incidence has increased cyclically with peaks occurring in 1983, 1986, 1990, and 1993 (1-3). This report summarizes national surveillance data for pertussis from January 1992 through June 1995 from CDC's National Public Health Surveillance System (NPHSS) and Supplementary Pertussis Surveillance System (SPSS) and assesses the effectiveness of pertussis vaccination in the United States during this period using vaccination coverage data from CDC's National Health Interview Survey (NHIS).
在疫苗接种前的时代(即20世纪40年代中期之前),百日咳是美国婴幼儿发病和死亡的主要原因。自1922年百日咳成为全国法定报告疾病以来,1934年报告的百日咳病例数最多(约260,000例);1923年百日咳相关死亡人数最多(约9000例)。1949年全细胞百日咳疫苗与白喉和破伤风类毒素联合疫苗(DTP)获得许可并在婴幼儿中广泛使用后,1976年报告的百日咳发病率降至历史最低点,为1010例(图1)。然而,自20世纪80年代初以来,报告的百日咳发病率呈周期性上升,在1983年、1986年、1990年和1993年出现高峰(1 - 3)。本报告总结了1992年1月至1995年6月美国疾病控制与预防中心国家公共卫生监测系统(NPHSS)和补充百日咳监测系统(SPSS)的全国百日咳监测数据,并利用疾病控制与预防中心国家健康访谈调查(NHIS)的疫苗接种覆盖率数据评估了这一时期美国百日咳疫苗接种的有效性。